Trial intelligence / Profile preview

Ketamine as Adjuvant to Lidocaine in IVRA

NCT02063620Completed

Sponsor
Düzce University
Start
Oct 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ketamine, sponsored by Düzce University. Primary endpoint: QT interval. Started Oct 2013; status: completed.

02

Drugs

ketamine

Beyond the preview

Go deeper on NCT02063620.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02063620.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call